Clinical Trial Update: Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated and compared the immune responses to two DTP-containing vaccines (Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hiberix) given at 6, 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• Tritanrix-HepB/Hib-MenAC
• Tritanrix-HepB/Hiberix

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis | Phase 3 | Status: COMPLETED